Lanean...
Continuation of metformin use after a diagnosis of cirrhosis significantly improved survival of patients with diabetes
BACKGROUND: The risks and benefits of metformin use in cirrhotic patients with diabetes are debated. Although data on a protective effect of metformin against liver cancer development have been reported, metformin is frequently discontinued once cirrhosis is diagnosed due to concerns about an increa...
Gorde:
| Argitaratua izan da: | Hepatology |
|---|---|
| Egile Nagusiak: | , , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2014
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4218882/ https://ncbi.nlm.nih.gov/pubmed/24798175 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hep.27199 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|